4//SEC Filing
Kammer Robert J 4
Accession 0001493152-18-015161
CIK 0001360214other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 6:20 PM ET
Size
4.9 KB
Accession
0001493152-18-015161
Insider Transaction Report
Form 4
Kammer Robert J
DirectorChairman of the Board10% Owner
Transactions
- Sale
Common Stock
2018-11-01$4.21/sh−10,000$42,100→ 899,827 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan, as amended, adopted by the Reporting Person.
Documents
Issuer
Imprimis Pharmaceuticals, Inc.
CIK 0001360214
Entity typeother
Related Parties
1- filerCIK 0001542484
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 6:20 PM ET
- Size
- 4.9 KB